Partnership with Baylor College of Medicine to develop HPV-specific T Cell therapy for all HPV-related cancers

Tessa Therapeutics and Baylor College of Medicine (Baylor) entered into a partnership to develop Baylor’s HPV-specific immunotherapy. Under the agreement signed in Feb 2015, Tessa Therapeutics has the exclusive right to license Baylor’s HPV-specific T Cell therapy for all HPV-related cancers including cervical and oropharyngeal cancers.